MoneyWorks4Me

The Revenue for the quarter ended  September 2022 of Rs. 1469.88 millions grew by 20.18 % from Rs. 1223.08 millions.Modest increase of 8.97% in the Net Profit was reported from. 174.71 millions to Rs. 190.38  millions.Operating profit surged to 289.79 millions from the corresponding previous quarter of 275.34 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1469.88 1223.08 20.18 2779.94 2354.38 18.08 5201.35 3406.08 52.71
Other Income 8.54 1.63 423.93 14.73 11.95 23.26 27.62 13.30 107.67
PBIDT 289.79 275.34 5.25 525.21 506.57 3.68 1079.38 815.32 32.39
Interest 4.49 26.92 -83.32 6.31 54.81 -88.49 64.07 56.18 14.04
PBDT 285.30 248.42 14.85 518.90 451.76 14.86 1015.31 759.14 33.74
Depreciation 28.19 23.18 21.61 58.57 45.45 28.87 100.80 41.88 140.69
PBT 257.11 225.24 14.15 460.33 406.31 13.30 914.51 717.26 27.50
TAX 66.73 50.53 32.06 121.32 94.36 28.57 195.04 177.27 10.02
Deferred Tax 6.21 7.06 -12.04 10.84 10.29 5.34 27.83 1.63 1607.36
PAT 190.38 174.71 8.97 339.01 311.95 8.67 719.47 539.99 33.24
Equity 364.37 364.37 0.00 364.37 364.37 0.00 364.37 315.00 15.67
PBIDTM(%) 19.72 22.51 -12.42 18.89 21.52 -12.19 20.75 23.94 -13.31
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..